Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months

https://doi.org/10.1016/S0376-8716(99)00063-0Get rights and content

Abstract

The aim of this study was to identify predictors of treatment success and of relapse, 1 and 6 months after inpatient opiate detoxification in an 8-bed unit in Geneva. Of all 73 patients admitted between June 1994 and June 1995, a majority (73%) successfully finished opiate detoxification. Detoxification was performed mainly with methadone tapering; the average duration of hospitalisation was 15 days. Factors associated with treatment failure were: cocaine abuse, presence of legal problems, and short duration of hospital stay. After 1 month, 65% of the patients were using drugs (half of them were dependent again, half of them had used occasionally) and 35% were completely abstinent (21% when excluding those in residential treatment). Predictors of rapid relapse were cocaine abuse and little concern with own psychological situation at baseline. After 6 months, 50% were physically dependent again, 13% had lapsed occasionally, 37% were abstinent (28% when excluding those in residential treatment). Only high benzodiazepine use at baseline was associated with medium term abstinence. Addiction severity index composite scores had considerably improved between baseline and 6 months. Prevention of relapse to opiate use after inpatient detoxification, especially for those with a concurrent cocaine abuse, should be improved.

Introduction

Compared with other types of substance abuse treatment, studies on inpatient opiate detoxification are rare. Especially, data on relapse after inpatient detoxification are lacking. Still, clinicians admit in general that relapse after inpatient detoxification is frequent (Duvall et al., 1963, Craig, 1984, Gossop et al., 1987, Gossop et al., 1989, Alling, 1992). In French-speaking settings, inpatient detoxification was, until recently, the most frequently used treatment, but to date studies evaluating its effectiveness in the short or long-term have not been published (Agence Nationale d’Accréditation et d’Evaluation en Santé, 1998)

Studies from English-speaking settings show that inpatient detoxification programmes differ considerably in length of treatment, type and intensity of pharmacological treatment or associated services offered, but that in general between 50 to 80% of the patients finish the treatment successfully (Gossop et al., 1982, Gossop et al., 1987, Gossop et al., 1989, San et al., 1989, Alling, 1992). Patient factors such as gender, age, duration of drug use are not associated with treatment success (Craig, 1984, San et al., 1989), whereas factors such as family and social support, and psychological or psychiatric status are inconsistently related to treatment outcome (Craig, 1984).

Studies on relapse to drug use after inpatient detoxification show that, in general, initial relapse occurs in the first few weeks after the end of treatment. Relapse rates vary between 9–50% at 6 months, but samples are often small and response rates low (Hunt and Odorroff, 1962, Duvall et al., 1963, Gossop et al., 1986, Gossop et al., 1987, Gossop et al., 1989). Gossop shows that certain subjects can take opiates after successful inpatient detoxification, without becoming dependent again, this event is called ‘lapse’ or ‘mistake’ (Marlatt and Gordon, 1985, Gossop et al., 1989). Relapse is thus defined as a return to dependence and daily use of the drug. The factors associated with relapse after inpatient detoxification are female gender, younger age, poly-drug use, intravenous drug use, absence of protective factors (family support, work, housing, access to care), social pressure and lack of confidence about the ability to maintain a drug-free life (Duvall et al., 1963, Winnick, 1964, Gossop et al., 1987, Gossop et al., 1990).

There are no published studies on the evaluation of inpatient detoxification programmes while using the Addiction severity index (ASI) as a baseline characteristic. The ASI is a standardised score of severity of addiction and is widely used in many studies evaluating other types of drug abuse treatment (McLellan et al., 1992).

The aim of this study is to describe the results of an inpatient opiate detoxification programme in Geneva and relapse rates at 1 and 6 months, to analyse the correlation between ASI characteristics and treatment outcome or relapse, and to assess the retention rate into treatment. It is the first study in this domain from a French-speaking community using the ASI and a systematic methodology to describe the evaluation of patients after inpatient detoxification.

Section snippets

Study setting

The Division of Substance Abuse offers methadone maintenance treatment, in- and out-patient detoxification and primary health care. The inpatient detoxification centre, the only one in Geneva, opened in 1986, is in a villa in an urban setting as part of a psychiatric hospital. There are eight beds, the waiting-list is 2–3 weeks. Admissions are voluntary, and can be for detoxification of opiates only or of multiple drugs, as well as for a medico-psycho-social crisis. The staff is

Baseline characteristics

Between 1st June 1994 and 1st June 1995 74 subjects were eligible for this study. One person refused to participate, so 73 patients were included (participation 98.9%). Of them 62% were male. The average age was 27 years (range 16–39), and average duration of opiate dependence 6 years (S.D. 5.5 years). Thirty-eight (52%) were dependent on heroin only, five (7%) on methadone only. Seven (10%) were dependent on heroin and other drugs, 20 (27%) on methadone and other drugs, three (4%) on codeine

Discussion

The main findings of this study are that in our specific context 73% of those seeking in-patient opiate detoxification completed the detoxification phase, and that at least 23% were free of all opiates after 6 months in their usual environment. Cocaine use was associated with high treatment failure and a high relapse rate after 1 month, whereas benzodiazepine use at baseline was associated with medium term abstinence.

The high-staffed inpatient opiate detoxification programme described offered

Acknowledgments

We wish to thank the patients and the staff of the ‘Villa les Crêts’ for their collaboration and time, and Pascal Dupont and Pierre El-Kohr for their help in data-collection.

References (22)

  • M. Gossop et al.

    Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment of treatment

    Br. Med. J.

    (1986)
  • Cited by (108)

    • Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study

      2022, Journal of Substance Abuse Treatment
      Citation Excerpt :

      Such an addition would greatly enhance the care provided, as it would expedite access to evidence-based measures such as MOUD. Prior studies have shown that detox is frequently used as part of the recovery process, but without further treatment the relapse rate is high (Broers et al., 2000; Strang et al., 2003). A recent study found that 61 % of all inpatient detoxification admissions result in readmission sometime in the future (Morgan et al., 2020), highlighting that many individuals with substance use are not successfully connected to services for further treatment options after completing detox (Williams et al., 2018).

    View all citing articles on Scopus
    1

    Dr Giner is currently with the General Direction of Drug Dependence in Valencia, Spain.

    View full text